Study ID: ABS-COPD-30065
Study Title
- Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Teva Identifier
- ABS-COPD-30065
ClinicalTrials.gov Identifier
- NCT03256695
Study Status
- Completed
Trial Condition(s)
- Chronic Obstructive Pulmonary Disease
Interventions
- Drug: Albuterol sulfate (ABS)
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 40 Years and older
Trial Duration
- September 28, 2017 - April 17, 2018
Phase
- Phase 3
Study Type
Interventional